Warner Chilcott

(

WCRX

) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 1.2%. By the end of trading, Warner Chilcott fell $0.20 (-1.0%) to $19.71 on light volume. Throughout the day, 3,672,061 shares of Warner Chilcott exchanged hands as compared to its average daily volume of 6,964,500 shares. The stock ranged in price between $19.64-$20.07 after having opened the day at $20.05 as compared to the previous trading day's close of $19.91. Other companies within the Health Care sector that declined today were:

Pingtan Marine Enterprise

(

PME

), down 61.1%,

Mast Therapeutics

(

MSTX

), down 38.6%,

Insmed

(

INSM

), down 18.7% and

TherapeuticsMD

(

TXMD

), down 13.5%.

Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women's healthcare, gastroenterology, urology, and dermatology markets. Warner Chilcott has a market cap of $5.0 billion and is part of the drugs industry. The company has a P/E ratio of 13.3, below the S&P 500 P/E ratio of 17.7. Shares are down 2.1% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Warner Chilcott a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Warner Chilcott

as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall.

On the positive front,

Onyx Pharmaceuticals

(

ONXX

), up 51.3%,

Bacterin International Holdings

(

BONE

), up 20.0%,

Spherix

(

SPEX

), up 19.3% and

Prima Biomed

(

PBMD

), up 18.9% , were all gainers within the health care sector with

Alexion Pharmaceuticals

(

ALXN

) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null